Lisa E. Humphrey

950 total citations
23 papers, 783 citations indexed

About

Lisa E. Humphrey is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lisa E. Humphrey has authored 23 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Oncology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lisa E. Humphrey's work include TGF-β signaling in diseases (14 papers), Cancer Cells and Metastasis (8 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Lisa E. Humphrey is often cited by papers focused on TGF-β signaling in diseases (14 papers), Cancer Cells and Metastasis (8 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Lisa E. Humphrey collaborates with scholars based in United States, Germany and Canada. Lisa E. Humphrey's co-authors include Michael G. Brattain, James K. V. Willson, Kathleen M. Mulder, Robert S. Kerbel, Gillian Howell, Dan Theodorescu, Lu‐Zhe Sun, Jennie Hauser, Elizabeth Zborowska and Rajinder S. Sawhney and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Lisa E. Humphrey

23 papers receiving 777 citations

Peers

Lisa E. Humphrey
Jennie Hauser United States
Tiffany A. LaFortune United States
Kathy A. Toy United States
NR Lemoine United Kingdom
H E Zhau United States
Dawn Steele United Kingdom
Vicki L. Hopwood United States
Duen‐Hwa Yan United States
Jennie Hauser United States
Lisa E. Humphrey
Citations per year, relative to Lisa E. Humphrey Lisa E. Humphrey (= 1×) peers Jennie Hauser

Countries citing papers authored by Lisa E. Humphrey

Since Specialization
Citations

This map shows the geographic impact of Lisa E. Humphrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa E. Humphrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa E. Humphrey more than expected).

Fields of papers citing papers by Lisa E. Humphrey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa E. Humphrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa E. Humphrey. The network helps show where Lisa E. Humphrey may publish in the future.

Co-authorship network of co-authors of Lisa E. Humphrey

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa E. Humphrey. A scholar is included among the top collaborators of Lisa E. Humphrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa E. Humphrey. Lisa E. Humphrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Humphrey, Lisa E., Lynette M. Smith, Surendra K. Shukla, et al.. (2019). Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy. Cancers. 11(9). 1327–1327. 27 indexed citations
2.
Zou, Yi, Gillian Howell, Lisa E. Humphrey, Jing Wang, & Michael G. Brattain. (2013). Ron Knockdown and Ron Monoclonal Antibody IMC-RON8 Sensitize Pancreatic Cancer to Histone Deacetylase Inhibitors (HDACi). PLoS ONE. 8(7). e69992–e69992. 20 indexed citations
3.
Zhou, Yunfei, Song Li, Jing Wang, et al.. (2006). Blockade of EGFR and ErbB2 by the Novel Dual EGFR and ErbB2 Tyrosine Kinase Inhibitor GW572016 Sensitizes Human Colon Carcinoma GEO Cells to Apoptosis. Cancer Research. 66(1). 404–411. 81 indexed citations
4.
Hu, Yi, Natalia Sergina, Gillian Howell, et al.. (2005). Reorganization of ErbB Family and Cell Survival Signaling after Knock-down of ErbB2 in Colon Cancer Cells. Journal of Biological Chemistry. 280(29). 27383–27392. 21 indexed citations
5.
Sawhney, Rajinder S., Bhavya Sharma, Lisa E. Humphrey, & Michael G. Brattain. (2003). Integrin α2 and Extracellular Signal-regulated Kinase Are Functionally Linked in Highly Malignant Autocrine Transforming Growth Factor-α-driven Colon Cancer Cells. Journal of Biological Chemistry. 278(22). 19861–19869. 30 indexed citations
6.
Sawhney, Rajinder S., et al.. (2002). Differences in Sensitivity of Biological Functions Mediated by Epidermal Growth Factor Receptor Activation with Respect to Endogenous and Exogenous Ligands. Journal of Biological Chemistry. 277(1). 75–86. 29 indexed citations
7.
Wang, Degeng, Sandip Patil, Wenhui Li, et al.. (2002). Activation of the TGFα autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells. Oncogene. 21(18). 2785–2796. 27 indexed citations
8.
Awwad, Rana, Lisa E. Humphrey, William M. Scovell, et al.. (1999). The EGF/TGFα response element within the TGFα promoter consists of a multi-complex regulatory element. Oncogene. 18(43). 5923–5935. 7 indexed citations
9.
Howell, Gillian, Lisa E. Humphrey, Barry L. Ziober, et al.. (1998). Regulation of Transforming Growth Factor α Expression in a Growth Factor-Independent Cell Line. Molecular and Cellular Biology. 18(1). 303–313. 16 indexed citations
10.
Jiang, Dianhua, Hai-Su Yang, James K. V. Willson, et al.. (1998). Autocrine Transforming Growth Factor α Provides a Growth Advantage to Malignant Cells by Facilitating Re-entry into the Cell Cycle from Suboptimal Growth States. Journal of Biological Chemistry. 273(47). 31471–31479. 37 indexed citations
11.
Wang, Degeng, Wenhui Li, Wen Jiang, et al.. (1998). Autocrine TGF? expression in the regulation of initiation of human colon carcinoma growth. Journal of Cellular Physiology. 177(3). 387–395. 15 indexed citations
12.
Howell, Gillian, Lisa E. Humphrey, Rana Awwad, et al.. (1998). Aberrant Regulation of Transforming Growth Factor-α during the Establishment of Growth Arrest and Quiescence of Growth Factor Independent Cells. Journal of Biological Chemistry. 273(15). 9214–9223. 17 indexed citations
13.
Jiang, Dianhua, Jiurong Liang, Lisa E. Humphrey, Hai-Su Yang, & Michael G. Brattain. (1998). Expression of TGFα autocrine activity in human colon carcinoma CBS cells is autoregulated and independent of exogenous epidermal growth factor. Journal of Cellular Physiology. 175(2). 174–183. 13 indexed citations
15.
Howell, Gillian, Barry L. Ziober, Lisa E. Humphrey, et al.. (1995). Reglation of autocrine gastrin expression by the TGFα autocrine loop. Journal of Cellular Physiology. 162(2). 256–265. 24 indexed citations
16.
Wang, Danhui, Thomas M. Birkenmeier, Junhua Yang, et al.. (1995). Release from quiescence stimulates the expression of integrin α5β1 which regulates DNA synthesis in human fibrosarcoma HT1080 cells. Journal of Cellular Physiology. 164(3). 499–508. 12 indexed citations
17.
Sun, Lu‐Zhe, et al.. (1994). Autocrine Transforming Growth Factor-β1 and β2 Expression Is Increased by Cell Crowding and Quiescence in Colon Carcinoma Cells. Experimental Cell Research. 214(1). 215–224. 25 indexed citations
18.
Sun, Lu‐Zhe, et al.. (1993). Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties.. PubMed. 4(2). 115–23. 62 indexed citations
19.
Mulder, Kathleen M., et al.. (1990). Evidence for c‐myc in the signaling pathway for TGF‐β in well‐differentiated human colon carcinoma cells. Journal of Cellular Physiology. 145(3). 501–507. 27 indexed citations
20.
Mulder, Kathleen M., et al.. (1990). Inhibitory effects of transforming growth factor beta 1 on mitogenic response, transforming growth factor alpha, and c-myc in quiescent, well-differentiated colon carcinoma cells.. Cancer Research. 50(23). 7581–6. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026